Clinical Trial Update: RECONFIRM - Study of AGN1 LOEP in Patients with Osteoporosis [NA]

View source ↗

Summary

RECONFIRM is a clinical study evaluating AGN1 LOEP in patients with osteoporosis; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• AGN1 LOEP

Snippet

Sponsor: AgNovos Healthcare, LLC | Conditions: Osteoporosis | NA | Status: RECRUITING